BioAtla, Inc.
BCAB • NASDAQ
BioAtla, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jay Short, with a market cap of $12.7M.
CEOJay Short
Next Earnings
Upcoming earnings announcement for BioAtla, Inc.
Date
Tuesday, May 5, 2026 (in 3 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.37
Earnings History
Past 12 earnings reports for BioAtla, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q4 2025 | -$0.16Est: -$0.36 | +55.6% | $2.0MEst: $700.0K | +185.7% |  10-K |
| Nov 13, 2025 | Q3 2025 | -$0.27Est: -$0.30 | +10.0% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.32Est: -$0.29 | -10.3% | - | — | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.26Est: -$0.29 | +10.3% | - | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.30Est: -$0.38 | +21.1% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.22Est: -$0.36 | +38.9% | $11.0M | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.44Est: -$0.44 | 0.0% | - | — | — |
| May 14, 2024 | Q1 2024 | -$0.48Est: -$0.54 | +11.1% | - | — | 10-Q |
| Mar 26, 2024 | Q4 2023 | -$0.56Est: -$0.79 | +29.1% | - | — | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.70Est: -$0.80 | +12.5% | - | — | — |
| Aug 1, 2023 | Q2 2023 | -$0.75Est: -$0.62 | -21.0% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.58Est: -$0.63 | +7.9% | - | — | 10-Q |